Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central Pharmaceutical CPC1 Joint Stock Company (CPC1) is a leading pharmaceutical enterprise in Vietnam, primarily engaged in the manufacturing, import, and distribution of medicines, vaccines, and medical devices. Established in 1956 and headquartered in Hanoi, the company serves as a critical commercial and logistics partner for multinational pharmaceutical corporations, including Sanofi, Johnson & Johnson, Pfizer, and GSK. CPC1 operates modern WHO-GMP certified manufacturing facilities for generic drug production and maintains a extensive cold chain network for specialized products. As a subsidiary of the Vietnam Pharmaceutical Corporation (Vinapharm) and a public entity listed on the UPCoM exchange, CPC1 is a central player in the development and supply of the Vietnamese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central Pharmaceutical.